TalkMed, a specialist cancer medical group, is controlled by group CEO Dr Ang Peng Tiam, who has an interest in 64.74% of the shares. Group COO Dr Khoo Kei Siong holds another 7.49%.
TalkMed Group says that it has received "interest" from "persons" who are considering the acquisition of a stake in the company.
"The discussions are preliminary at this stage and there is no assurance that a transaction will take place," says the company on April 6.
